Products

Gastric Alimetry
Alimetry
Gastroenterology AI
Gastric Alimetry is a non-invasive, AI-powered wearable medical device and system for Body Surface Gastric Mapping, designed to aid in the diagnosis of various gastric disorders by recording and analyzing gastric electrophysiology and patient-reported symptoms.

See all 1 product →

About Alimetry

Alimetry is a healthcare AI company specializing in advanced non-invasive diagnostics for gastrointestinal (GI) disorders. Their flagship product, Gastric Alimetry, is a wearable medical device that utilizes body surface gastric mapping to record and analyze the natural electrical activity of the stomach. This system, coupled with a patient symptom logging app and gut-brain wellbeing surveys, provides clinicians with objective, data-driven insights into gastric function, motility, and electrophysiology.

The technology is designed to aid in the diagnosis of various gastric disorders, including those that are often challenging to identify with conventional methods, such as functional dyspepsia and gastroparesis. By integrating AI for data processing, Alimetry aims to simplify, accelerate, and enhance the accuracy of the diagnostic process, moving away from lengthy trial-and-error approaches towards personalized medicine. The device has secured multiple FDA clearances and a CPT III reimbursement code, facilitating its adoption and integration into clinical practice across hospitals and clinics.

Alimetry’s focus extends to transforming care for patients suffering from chronic gut symptoms like abdominal pain, indigestion, nausea, and vomiting, which affect a significant portion of the population. The company is also exploring future applications of its proprietary technology, including potential expansion into pediatric diagnostics and the assessment of colonic health.

Focus Areas

Gastrointestinal diagnostics wearable medical devices gastric motility electrophysiology AI-powered analytics digital health non-invasive diagnostics gut-brain axis

Business Intelligence

Key InvestorsGD1 (Global From Day One), Olympus Innovation Ventures, American Gastroenterological Association GI Opportunity Fund, Icehouse Ventures, Movac, IP Group, Matū Group, UniServices, K1W1, Longview Innovation, Cerity Partners Ventures, MedTech Innovator
PartnershipsOver 40 hospitals and clinics worldwide (US, UK, New Zealand), GI pharma firms, MedBoard (regulatory intelligence platform)
TechnologyAlimetry's technology platform combines high-density electrode arrays in a wearable patch to capture faint gastric electrical signals from the skin's surface (Body Surface Gastric Mapping). These signals are then processed using AI-driven algorithms in the cloud to provide high-resolution analysis of stomach activity. The platform also integrates a patient symptom logging app and gut-brain health questionnaires for a multimodal assessment.
FDA Clearances5 cleared products (estimated)

What Physicians Need to Know

Gastrointestinal Diagnostics
Alimetry specializes in providing objective, data-driven insights to aid in the diagnosis of various gastric disorders, particularly those with unexplained chronic symptoms like nausea, bloating, and pain, which have been difficult to solve with conventional methods.
Wearable Medical Devices
Their flagship product, Gastric Alimetry, is a first-in-class wearable patch equipped with high-density electrode arrays designed to non-invasively capture the stomach's natural electrical rhythms.
Gastric Motility & Electrophysiology
The technology measures and analyzes the stomach's electrical signals (electrogastrography) through Body Surface Gastric Mapping (BSGM), providing real-time insights into gastric motility patterns and pacemaker cell activity, akin to an ECG for the heart.
AI-Powered Analytics
Faint gastric signals captured by the device are processed using advanced AI-driven algorithms in the cloud. This AI converts complex data into significant clinical biomarkers, enabling sophisticated analysis and benchmarking against thousands of diverse test cases.
Digital Health & Non-Invasive Diagnostics
Alimetry offers a comprehensive digital health platform that includes a patient app for real-time symptom logging during the test. This non-invasive approach provides a high-resolution assessment of gastric function, avoiding the need for invasive procedures like endoscopy or swallowable capsules.
Gut-Brain Axis Integration
The platform integrates patient-reported symptoms, including psychological factors, to help differentiate between gut-related problems and those influenced by nerve or brain dysfunction, reflecting the growing understanding of the gut-brain axis.
Physician Tip

For physicians, Alimetry stands out by offering unprecedented clarity in diagnosing chronic gastric symptoms, moving beyond 'trial and error' to provide objective, data-driven insights. This enables more personalized and effective treatment pathways for conditions like gastroparesis, chronic nausea, and functional dyspepsia. The non-invasive nature of the Gastric Alimetry test improves the patient diagnostic journey, making it safer and more comfortable. Furthermore, the system provides insights into the 'software of the gut' (what the stomach is actively doing) rather than just its anatomy, which is crucial for understanding functional disorders. With established FDA clearances and a dedicated CPT III reimbursement code in the U.S., Alimetry offers a clear and accessible diagnostic tool that can significantly reduce the time, cost, and complexity of diagnosis, ultimately leading to faster and more accurate patient management.

Alimetry's technology stack includes a wearable device (Gastric Alimetry reader and single-use electrode array), a dedicated patient app for symptom tracking (designed for iPad miniu00ae), and a cloud-based platform for AI-powered data analysis and report generation. The system is designed to provide a comprehensive Gastric Alimetry Report to clinicians via the Alimetry Cloud, summarizing gastric electrophysiology, patient symptom patterns, and gut-brain psychometrics. The company is also exploring partnerships with GI pharma firms to monitor the effects of therapies like GLP-1s, optimize dosing, and stratify patients in trials.

Products by Alimetry

1 product in the directory

Gastric Alimetry
Alimetry
Gastroenterology AI
Gastric Alimetry is a non-invasive, AI-powered wearable medical device and system for Body Surface Gastric Mapping, designed to aid in the diagnosis of various gastric disorders by recording and analyzing gastric electrophysiology and patient-reported symptoms.

Reviews & Opinions

No web reviews on file yet for Alimetry. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about Alimetry.

Loading videos...

Videos load interactively. If none appear, search YouTube for Alimetry →

View all on YouTube

Press & Coverage

Alimetry (Press Release)
Alimetry Secures FDA Clearance for AI Analysis System for Gastric Function
Alimetry received its fourth U.S. regulatory clearance for an AI-powered update to its noninvasive wearable device, Gastric Alimetry, which aids in diagnosing gastric diseases.
2026-02
Alimetry (Press Release)
International Gastroenterology Expert Working Group Publishes Consensus Framework
An international expert working group in gastroenterology has published a consensus framework, likely involving Alimetry's technology given its prominence in gut diagnostics.
2026-07
BioWorld
Alimetry brings first wearable gut diagnostic to market
Alimetry is expanding the commercialization of its wearable Gastric Alimetry device, which measures gut function and has achieved multiple FDA clearances and a dedicated reimbursement code in the U.S.
2025-09
Olympus America (Press Release)
AI Integrated Wearables for Gut Health Diagnosis: Olympus Innovation Ventures Invests in Alimetry
Olympus Innovation Ventures joined other investors in an oversubscribed Series A2 funding round for Alimetry, enabling the company to expand its AI-powered wearable device for gut disorder diagnosis in the U.S.
2024-10
PR Newswire
Alimetry revolutionises gut health diagnosis by integrating AI into its wearable device, raises US $18m to fuel next phase of growth
Alimetry secured an oversubscribed US $18 million Series A2 financing round to commercialize its AI-powered wearable gut health monitoring device, driven by increased adoption in U.S. hospitals, its fourth FDA clearance, and a CPT III reimbursement code.
2024-10
IP Group
Alimetry Secures CPT III Reimbursement Code for the Gastric Alimetry Test and Announces Positive Clinical Study Results
Alimetry announced a new American Medical Association (AMA) CPT III code for Body Surface Gastric Mapping, specifically for its Gastric Alimetry test, effective July 1, 2024, marking a significant step towards broader clinical integration and reimbursement.
2024-02
PMC (medRxiv preprint)
Gastric Alimetryu00ae improves patient phenotyping in gastroduodenal disorders compared to gastric emptying scintigraphy alone
A preprint article suggests that Gastric Alimetry provides a 1.5x higher yield for detecting motility abnormalities and identifies 2.7x more specific patient categories than traditional gastric emptying scintigraphy.
2023-02
IP Group Australia (Press Release)
Alimetry announces US FDA Clearance for Gastric Alimetry u2013 A Breakthrough Non-Invasive Wearable Device for Gut Diagnostics
Alimetry received U.S. FDA clearance for Gastric Alimetry, a non-invasive wearable medical device designed to aid in the diagnosis of gastric disorders, and launched Alimetry Inc. to market the device in the U.S.
2022-07

Frequently Asked Questions

Alimetry's flagship product, Gastric Alimetry, is a wearable, non-invasive medical device designed for Body Surface Gastric Mapping to diagnose various gastric disorders. It detects the stomach's electrical rhythms from the skin's surface, similar to an ECG for the heart, providing objective measurements of gastric motility and electrophysiology.
Alimetry's platform utilizes a wearable device that records gastric electrophysiology, which is then sent to the cloud for advanced, AI-powered analysis using smart algorithms. This process generates an auto-generated Gastric Alimetry Report, offering clinicians objective, data-driven insights to aid in diagnosis and personalized treatment. The accompanying app also allows patients to log symptoms and complete gut-brain health questionnaires, providing a multimodal assessment.
Gastric Alimetry is indicated as an aid in the diagnosis of various gastric disorders, including functional dyspepsia, gastroparesis, and chronic nausea and vomiting syndromes. The platform also incorporates gut-brain health questionnaires and features to aid in the diagnosis of gut hypersensitivity and common 'Gut-Brain-Axis' disorders, which are often linked to mental well-being.
Alimetry has secured multiple FDA clearances for its Gastric Alimetry system, with its fourth clearance enabling broader adoption. The American Medical Association has also established a Category III CPTu00ae code (0868T, effective July 1, 2024) for Body Surface Gastric Mapping, which facilitates data collection and allows for reimbursement, making the product accessible in hospitals and private clinics.
Alimetry offers an Education Hub and opportunities for clinical evaluations and involvement in their Community User Group to support clinicians. While specific pricing details are often negotiated, the cost for a self-paying patient for the Gastric Alimetry test, analysis, and report can be around u00a31,875 (approximately $2,300 USD), and the company currently sells hardware to hospitals without additional licensing or software fees, though this may change.
Alimetry, founded in 2019, has demonstrated strong company stability, raising over NZ$50 million across three funding rounds, including an oversubscribed US$18 million Series A2 round in October 2024. Key investors and partners include GD1, American Gastroenterological Association (AGA) GI Opportunity Fund, Olympus Innovation Ventures, Movac, IP Group, and the University of Auckland Inventor's Fund.

Investors

Who's funded Alimetry.

Related Companies

Google DeepMind is a leading artificial intelligence (AI) research laboratory, a subsidiary of Alphabet Inc., dedicated to developing advanced AI systems to benefit humanity. The company focuses on creating general-purpose AI that can learn and solve complex problems, drawing inspiration from neuroscience and machine learning. Their work spans various fields, including healthcare, scientific discovery, and […]

TalkToMedi is a Canadian healthcare AI company that has developed a clinical-grade voice AI platform called MEDI. This platform is designed to automate patient communication and administrative tasks for medical clinics, including family medicine, specialty clinics, allied health, and physiotherapy. MEDI handles high-volume patient calls, automating appointment inquiries, booking, rescheduling, and cancellations based on the […]

Menaela is an AI-first practice management system designed for solo practitioners, small private clinics, and clinic owners. It integrates patient communication, scheduling, CRM, and medical documentation into a single platform, aiming to replace multiple disconnected tools and bots. The system features an AI practice manager that understands natural-language requests, utilizes real clinic data, and performs […]

Avie (avie.me) is a healthcare AI company that focuses on providing a next-generation, whole-person health approach, bridging the gap between clinical and holistic care. The company connects individuals with providers and clinicians who can support their unique physical, emotional, cognitive, and logistical needs. Avie emphasizes fusing physical and mental best practices to enhance overall health, […]

Saile is a physician-founded healthcare technology company that addresses critical inefficiencies in healthcare staffing and credentialing. Their AI-powered platform acts as a “universal credential passport” for physicians, centralizing and managing all medical licenses, certifications, and CME credits in one secure, portable vault. This system aims to significantly reduce the administrative burden and delays associated with […]

Data Capture Experts (DCE) is an Australian-based healthcare AI company that is at the forefront of digital health transformation. They specialize in developing and implementing digital health platforms that integrate data, technology, and human-centered design to create intuitive and connected healthcare systems. Their flagship platform, DC2Vue, is designed to go beyond traditional Electronic Medical Records […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.